BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 19710462)

  • 1. An accessory role for B cells in the IL-12-induced activation of resting mouse NK cells.
    Haddad EA; Senger LK; Takei F
    J Immunol; 2009 Sep; 183(6):3608-15. PubMed ID: 19710462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
    Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
    Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cells from protein kinase C theta-/- mice stimulated with interleukin-12 are deficient in production of interferon-gamma.
    Page KM; Chaudhary D; Goldman SJ; Kasaian MT
    J Leukoc Biol; 2008 May; 83(5):1267-76. PubMed ID: 18263766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.
    Lauwerys BR; Renauld JC; Houssiau FA
    Cytokine; 1999 Nov; 11(11):822-30. PubMed ID: 10547269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
    Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
    Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A
    Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic background influences natural killer cell activation during bacterial peritonitis in mice, and is interleukin 12 and interleukin 18 independent.
    Scott MJ; Hoth JJ; Gardner SA; Peyton JC; Cheadle WG
    Cytokine; 2004 Nov; 28(3):124-36. PubMed ID: 15473954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement.
    Leite-De-Moraes MC; Hameg A; Arnould A; Machavoine F; Koezuka Y; Schneider E; Herbelin A; Dy M
    J Immunol; 1999 Dec; 163(11):5871-6. PubMed ID: 10570271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
    Hafner M; Falk W; Echtenacher B; Männel DN
    Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor-dependent IL-12 production by dendritic cells is required for activation of natural killer cell-mediated Type-1 immunity induced by Chrysanthemum coronarium L.
    Tanaka S; Koizumi S; Masuko K; Makiuchi N; Aoyagi Y; Quivy E; Mitamura R; Kano T; Ohkuri T; Wakita D; Chamoto K; Kitamura H; Nishimura T
    Int Immunopharmacol; 2011 Feb; 11(2):226-32. PubMed ID: 21144920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell suppression of IgM production.
    Che S; Huston DP
    Nat Immun; 1994; 13(5):258-69. PubMed ID: 7833625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-gamma-inducing factors but enhances NK cell production of IFN-gamma.
    Shibata Y; Foster LA; Kurimoto M; Okamura H; Nakamura RM; Kawajiri K; Justice JP; Van Scott MR; Myrvik QN; Metzger WJ
    J Immunol; 1998 Oct; 161(8):4283-8. PubMed ID: 9780204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 2 induces gamma-interferon production: participation of macrophages and NK-like cells.
    Kawase I; Brooks CG; Kuribayashi K; Olabuenaga S; Newman W; Gillis S; Henney CS
    J Immunol; 1983 Jul; 131(1):288-92. PubMed ID: 6408175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12.
    van de Wetering D; de Paus RA; van Dissel JT; van de Vosse E
    Int Immunol; 2009 Feb; 21(2):145-53. PubMed ID: 19088061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell co-receptor CD72 is expressed on NK cells and inhibits IFN-gamma production but not cytotoxicity.
    Alcón VL; Luther C; Balce D; Takei F
    Eur J Immunol; 2009 Mar; 39(3):826-32. PubMed ID: 19197938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salmonella typhimurium induces IFN-gamma production in murine splenocytes. Role of natural killer cells and macrophages.
    Ramarathinam L; Niesel DW; Klimpel GR
    J Immunol; 1993 May; 150(9):3973-81. PubMed ID: 8473744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
    Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z
    Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells induce activated murine B cells to secrete Ig.
    Snapper CM; Yamaguchi H; Moorman MA; Sneed R; Smoot D; Mond JJ
    J Immunol; 1993 Nov; 151(10):5251-60. PubMed ID: 8228222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs.
    Schleicher U; Liese J; Knippertz I; Kurzmann C; Hesse A; Heit A; Fischer JA; Weiss S; Kalinke U; Kunz S; Bogdan C
    J Exp Med; 2007 Apr; 204(4):893-906. PubMed ID: 17389237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo effects of mercuric chloride on thymic endocrine activity, NK and NKT cell cytotoxicity, cytokine profiles (IL-2, IFN-gamma, IL-6): role of the nitric oxide-L-arginine pathway.
    Santarelli L; Bracci M; Mocchegiani E
    Int Immunopharmacol; 2006 Mar; 6(3):376-89. PubMed ID: 16428073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.